Frequently Asked Questions
Get answers to common questions about clinical programming, CDISC standards, regulatory submissions, and outsourcing. We're here to help you make informed decisions.
CDISC & Data Standards
What is SDTM and why is it required?
SDTM (Study Data Tabulation Model) is a standardized format for organizing and presenting clinical trial data to regulatory agencies like the FDA. It ensures consistency, traceability, and compliance across all clinical submissions. Without SDTM standardization, regulatory review is delayed and data quality issues become harder to identify.
What is ADaM and how does it differ from SDTM?
ADaM (Analysis Data Model) is the standardized format for analysis datasets used in statistical reporting and FDA submissions. While SDTM captures raw data as it was collected, ADaM contains derived variables, analysis populations, and structured datasets ready for statistical analysis. Both are required for FDA submissions.
Why is CDISC standardization important for FDA submissions?
CDISC standards ensure your data is submission-ready, audit-compliant, and immediately understood by FDA reviewers. Standardized data reduces review cycles, prevents costly resubmissions, and accelerates approval timelines. The FDA expects CDISC-compliant datasets—deviation from standards can trigger deficiency letters.
Regulatory Submissions
What is included in an FDA submission package?
An FDA submission package includes SDTM and ADaM datasets, Define.xml (dataset documentation), Study Data Reviewer's Guide (SDRG), Analysis Data Reviewer's Guide (ADRG), and statistical tables/listings/figures. VClinical Biostats prepares all components in FDA-ready format, validated for compliance and completeness.
What is Define.xml and why is it critical?
Define.xml is machine-readable metadata that documents every variable in your SDTM and ADaM datasets—definitions, origins, validation rules, and relationships. It's FDA-required and enables automated validation and traceability. Without Define.xml, regulators cannot verify dataset integrity or audit your trial data effectively.
How are FDA submission packages prepared?
We follow a structured process: extract and map raw data to SDTM standards, create derived ADaM analysis datasets, generate Define.xml documentation, prepare reviewer's guides with data specifications, validate all deliverables using Pinnacle 21, and conduct peer review. Every package is audit-trail documented and submission-ready.
Outsourcing & Data Security
Why should we outsource clinical programming?
Outsourcing clinical programming reduces internal headcount costs, accelerates timelines through specialized expertise, and provides access to CDISC and FDA submission expertise that's expensive to build in-house. VClinical Biostats' global delivery model (US + India) delivers regulatory-ready outputs at 40-50% cost savings compared to full-time staff.
How is data security maintained?
We maintain HIPAA and 21 CFR Part 11 compliance with encrypted data transfer, secure servers, role-based access controls, and audit logging. Data is segregated by trial and accessed only by assigned team members. All personnel sign NDAs and complete regulatory compliance training. Your clinical data is treated with the same security standards as your internal IT.
What is the typical timeline for clinical programming deliverables?
Timelines depend on trial complexity, dataset size, and scope. SDTM mapping typically takes 4-8 weeks; ADaM analysis datasets 3-6 weeks; FDA submission packages 6-10 weeks. Our global team enables accelerated delivery—many sponsors see 20-30% faster turnaround compared to traditional single-location CROs. We provide detailed project plans upfront.
About VClinical Biostats
What is your experience with clinical programming?
VClinical Biostats has a 10-member team with deep expertise in CDISC standardization, SAS programming, and regulatory submissions across Phase I-IV trials. Our team averages 3+ years of end-to-end clinical trial experience and holds certifications in SAS and regulatory compliance. We've supported trials across oncology, autoimmune, rare disease, neurology, and other therapeutic areas.
How does VClinical Biostats ensure quality?
Quality is built into every step: peer review of all code and specifications, Pinnacle 21 validation of SDTM/ADaM compliance, independent QA testing, and regular client communication. We maintain audit trails for all deliverables and conduct pre-submission reviews to catch issues before FDA submission. Our goal is zero deficiencies and first-time approval.
How does your US + India delivery model work?
Our Austin headquarters manages client relationships, regulatory oversight, and quality assurance. Our India operations center delivers the programming work, enabling cost savings and accelerated timelines. All work is US-managed, HIPAA-compliant, and subject to the same quality standards. You get global efficiency without sacrificing regulatory compliance or communication.
Still have questions?
Our team is ready to discuss your specific clinical trial needs and provide tailored solutions. Reach out for a consultation.
Industry Resources & Insights
Stay informed on the latest developments in clinical data standardization, regulatory compliance, and biostatistics best practices. Our curated resources help sponsors and CROs navigate complex trial requirements with confidence.
Guide to SDTM and ADaM Standardization
Understand the fundamentals of Study Data Tabulation Model (SDTM) and Analysis Data Model (ADaM) frameworks. Learn how proper standardization accelerates FDA submissions and ensures regulatory compliance.
FDA Submission Package Preparation Best Practices
Navigate the complexities of FDA submission packages with our comprehensive guide. Covers Define.xml, reviewer's guides, and quality assurance checkpoints that ensure submission-ready deliverables.
Clinical Data Management and Quality Assurance
Explore best practices for maintaining data integrity, implementing quality controls, and ensuring compliance with regulatory standards throughout the data lifecycle.
CDISC Compliance and Regulatory Updates
Stay current with CDISC standards, FDA guidance documents, and regulatory changes affecting clinical trial data management. Includes updates on restricted terminology and controlled vocabularies.
Cost-Effectiveness of Outsourced Clinical Programming
Discover how strategic outsourcing to global CROs delivers regulatory-ready deliverables while optimizing project budgets. Includes ROI analysis and resource allocation strategies.
Safety and Pharmacovigilance Reporting Standards
Understand requirements for adverse event reporting, safety summaries, and pharmacovigilance data management. Ensures timely and compliant safety communications throughout trial lifecycle.
Current Industry Trends
Increased CDISC Standardization Demand
Regulatory agencies increasingly require SDTM and ADaM compliance from Phase I onwards, driving earlier standardization adoption across all trial programs.
Global Outsourcing Growth
Sponsors leverage global CRO networks to accelerate timelines and optimize costs while maintaining regulatory compliance and data quality standards.
Enhanced Data Security Focus
Rising emphasis on data encryption, access controls, and audit trails reflects heightened regulatory scrutiny around clinical data protection and integrity.
Key Regulatory Resources
Access official guidance documents and standards from regulatory authorities and standards organizations:
Need Expert Guidance?
Our team stays current on regulatory trends and industry best practices. Discuss how we can support your clinical trial data standardization and regulatory submission strategy.